Products for Research Use Only
RegisterLogin

Begelomab

CAT: 0804-HY-P99466-01Size: 1 mgDry Ice: YesHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-P99466-01Size:1 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
Begelomab (SAND-26) is a murine IgG2b monoclonal antibody against DPP-4/CD26. Begelomab can be used for the research of severe refractory idiopathic inflammatory myopathy[1][2].
CAS Number
1403744-56-8
Product Name Alternative
SAND-26
UNSPSC
12352203
Target
Dipeptidyl Peptidase
Type
Inhibitory Antibodies
Related Pathways
Metabolic Enzyme/Protease
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/begelomab.html
Purity
95.0
Solubility
H2O
Smiles
[Begelomab]
Molecular Weight
(144.78 kDa)
References & Citations
[1]Lorenzo RD, et, al. Begelomab for severe refractory dermatomyositis: A case report. Medicine (Baltimore) . 2021 Mar 5;100 (9) :e24372. |[2]Ojha R, et, al. Designing of a bispecific antibody against SARS-CoV-2 spike glycoprotein targeting human entry receptors DPP4 and ACE2. Hum Immunol. 2022 Apr;83 (4) :346-355.
Shipping Conditions
Dry Ice
Storage Conditions
Store at -80°C for 2 years
Scientific Category
Inhibitory Antibodies
Clinical Information
Phase 3

Alternative Products

CatalogName
MBS5818847Begelomab
GTR18337850-01Begelomab Antibody
HB015016-01Research Grade Begelomab
KBI1178KRIBIOLISA™ Begelomab ELISA
E55B0326Begelomab (Reference antibody)
ICH5382-5mgBegelomab Biosimilar - Research Grade
C00312-1mg*25Begelomab (Anti-DPP4 / CD26)
591698Begelomab (DPP4, TP103, CD26)
048283DPP4/CD26 (begelomab) discontinued
GTR18780410-01(Begelomab) Biosimilar Reference Antibody

Popular Products